BioMarin
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioMarin and other ETFs, options, and stocks.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
BMRN Key Statistics
BMRN News
Citi believes data from BioMarin’s (BMRN) ongoing CANOPY trial for the treatment of achondroplasia and other skeletal dysplasia at the International Skeletal Dy...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key...
BioMarin Pharmaceutical announced that positive data from the CANOPY clinical program evaluating VOXZOGO, or vosoritide, in children with achondroplasia and oth...
Analyst ratings
79%
of 28 ratingsMore BMRN News
Scotiabank analyst George Farmer lowered the firm’s price target on BioMarin to $78 from $95 and keeps a Sector Perform rating on the shares. While the firm is...
Wells Fargo lowered the firm’s price target on BioMarin to $90 from $115 and keeps an Overweight rating on the shares. The firm expects competitive TransCon dat...
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term Ascendis Pharma A/S (NASDAQ:ASND) released to...
Ascendis Rockets — And Hammers BioMarin — On New Results For Growth Drug...
